These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6800819)

  • 1. Reduction of plasma and urinary vasopressin during treatment of severe hypertension by captopril.
    Thibonnier M; Soto ME; Menard J; Aldiger JC; Corvol P; Milliez P
    Eur J Clin Invest; 1981 Dec; 11(6):449-53. PubMed ID: 6800819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of captopril in hypertension.
    Maruyama A; Ogihara T; Naka T; Mikami H; Hata T; Nakamaru M; Iwanaga K; Kumahara Y
    Clin Pharmacol Ther; 1980 Sep; 28(3):316-23. PubMed ID: 6996895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of captopril on blood pressure, electrolytes, and certain hormones in hypertension.
    Guillevin L; Lardoux MD; Corvol P
    Clin Pharmacol Ther; 1981 Jun; 29(6):699-704. PubMed ID: 7014072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril, aldosterone and urinary kallikrein in primary hypertension.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Clin Exp Hypertens A; 1983; 5(4):523-9. PubMed ID: 6342863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.
    Waeber B; Gavras I; Brunner HR; Cook CA; Charocopos F; Gavras HP
    Am Heart J; 1982 Mar; 103(3):384-90. PubMed ID: 6278905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.
    Ueda Y; Honda M; Hatano M
    Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of captopril on blood pressure and on the renin-angiotensin-aldosterone system in coarctation of the aorta.
    Fallo F; Maragno I; Merola P; Mantero F
    Clin Exp Hypertens A; 1983; 5(3):321-8. PubMed ID: 6340859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of arterial blood pressure, plasma renin activity and plasma aldosterone concentration to long-term administration of captopril in patients with severe, treatment-resistant malignant hypertension.
    McCaa CS; Langford HG; Cushman WC; McCaa RE
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():371s-373s. PubMed ID: 396084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting enzyme inhibition with captopril in patients with primary hyperaldosteronism.
    Luderer JR; Demers LM; Harrison TS; Hayes AH
    Clin Pharmacol Ther; 1982 Mar; 31(3):305-11. PubMed ID: 6277545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of single dose administration of angiotension covering enzyme inhibitor (captopril) on blood pressure, plasma renin activity and plasma aldosterone in patients with essential hypertension. A proposal for the captopril test.
    Kodama K; Morotomi Y; Kida O; Higa T; Someya N; Kondo K; Tanaka K
    Nihon Jinzo Gakkai Shi; 1984 Sep; 26(9):1243-9. PubMed ID: 6392644
    [No Abstract]   [Full Text] [Related]  

  • 14. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
    Riegger GA; Steilner H; Hayduk K; Liebau G
    Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
    Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T
    Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
    Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
    Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose response in captopril therapy of hypertension.
    Lijnen P; Fagard R; Staessen J; Verschueren LJ; Amery A
    Clin Pharmacol Ther; 1980 Sep; 28(3):310-5. PubMed ID: 6250759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
    Ogihara T; Maruyama A; Hata T; Mikami H; Nakamaru M; Naka T; Ohde H; Kumahara Y
    Clin Pharmacol Ther; 1981 Sep; 30(3):328-35. PubMed ID: 6268347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of captopril on renal hemodynamics in hypertensive patients.
    Duchin KL; Willard DA
    J Clin Pharmacol; 1984; 24(8-9):351-9. PubMed ID: 6384279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
    Sassano P; Pedrinelli R; Magagna A; Abdel-Haq B; Salvetti A
    Am J Cardiol; 1982 Apr; 49(6):1574-6. PubMed ID: 6280486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.